| AC451 |
Multiple organ condyloma acuminatum tissue array, 45 cases_45 cores |
|
425.00 € |
- |
US Biomax |
| AD2081 |
Adrenal gland disease spectrum (adrenal cancer progression) tissue array, 100 cases_200 cores |
|
585.50 € |
- |
US Biomax |
| AG801 |
Adrenal tumor tissue array, 80 cases_80 cores |
|
341.54 € |
- |
US Biomax |
| AMS541 |
Mouse(FBV strain) normal tissue array, cover 22 organs_anatomic sites, 3 cases_54 cores |
|
288.90 € |
- |
US Biomax |
| AMS542 |
Mouse(KM strain) normal tissue array, cover 22 organs_anatomic sites, 3 cases_54 cores |
|
288.90 € |
- |
US Biomax |
| AMS543 |
Skin squamous cell carcinoma (SCC) tissue array, 80 cases_80 cores, no overlaps with SK801; ihc Anti-Cytokeratin (High MW) confirmed |
|
276.38 € |
- |
US Biomax |
| AMS544 |
Mouse normal tissue array, covering 22 organ_anatomic sites, 3 cases_54 cores |
|
288.90 € |
- |
US Biomax |
| ART661 |
Rat(Wistar strain) normal tissue array, covering all major organs, non_overlapping with ART662, 22 cases_66 cores |
|
288.90 € |
- |
US Biomax |
| ASM221 |
Cyno monkey normal tissue array, 22 cases_22 cores |
|
288.90 € |
- |
US Biomax |
| BB01011 |
Gastric ulcer tissue array, 14 cases _24 cores |
|
205.44 € |
- |
US Biomax |
| BC000110 |
Colorectal cancer tissue array, 85 cases_170 cores |
|
509.75 € |
- |
US Biomax |
| BC000111 |
Multiple organ cancer tissue array, 39 cases_39 cores |
|
242.68 € |
- |
US Biomax |
| BC000119 |
Multi_organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases_200 cores |
|
585.50 € |
- |
US Biomax |
| BC00012 |
Multiple organ diseased tissue array, 30 cases_60 cores, replaced by MC801 |
|
205.44 € |
- |
US Biomax |
| BC000120 |
Multi_organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases_200 cores |
|
585.50 € |
- |
US Biomax |
| BC00014 |
Multiple organ diseased tissue array, 63 cases_63 cores, replaced by MC631 |
|
205.44 € |
- |
US Biomax |
| BC00016 |
Multiple organ diseased tissues, 54 cases_54 cores, replaced by MC541 |
|
205.44 € |
- |
US Biomax |
| BC00019 |
Multiple organ squamous cell carcinoma tissue array, 63 cases_63 cores |
|
296.60 € |
- |
US Biomax |
| BC00111 |
Multiple organ normal and diseased tissue array (replaced by MCN601), 54 cases_60 cores |
|
296.60 € |
- |
US Biomax |
| BC001111 |
Multiple organ normal and diseased tissue array, 58 cases_60 cores, replaced by MCN601 |
|
296.60 € |
- |
US Biomax |
| BC001113 |
Esophageal adenocarcinoma, cardia adenocarcinoma, normal esophageal and cardia tissue array, 50 cases_50 cores (previously cat_ ES501) |
|
242.68 € |
- |
US Biomax |
| BC00112 |
Multiple organ paired normal and cancer (8 types) tissue array, 48 cases_48 cores |
|
205.44 € |
- |
US Biomax |
| BC001128 |
Top five cancer tissue array, including TNM and pathology grade, 148 cases_175 cores |
|
510.36 € |
- |
US Biomax |
| BC00113 |
Multiple organs tumor and normal tissue, 48 cases_48 cores |
|
242.68 € |
- |
US Biomax |
| BC001130 |
Pancreatic carcinoma and multi_organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases_121 cores |
|
356.95 € |
- |
US Biomax |
| BC001134 |
Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases_150 cores |
|
509.75 € |
- |
US Biomax |
| BC00114 |
Multiple organ normal and diseased tissue array, 36 cases_60 cores |
|
296.60 € |
- |
US Biomax |
| BC00115 |
Multiple organ normal and diseased tissue array, 44 cases_64 cores, replaced by MC802 |
|
296.60 € |
- |
US Biomax |
| BC00116 |
Carcinoma with adjacent_tissue combined panel tissue array, 44 cases_48 cores |
|
296.60 € |
- |
US Biomax |
| BC00119 |
Multiple organ diseased tissue array, 32 cases_32 cores, replaced by MC483 |
|
205.44 € |
- |
US Biomax |
| BC00432 |
Multiple organ tumor and adjacent normal tissue array, 39 cases_43 cores |
|
205.44 € |
- |
US Biomax |
| BC01001 |
Tissue array of gastric diseases biopsied from gastroscope, including TNM, clinical stage and pathology grade, 18 cases_18 cores |
|
296.60 € |
- |
US Biomax |
| BC01011 |
Stomach carcinoma (multi_tissue combined panel) tissue array, 24 cases _72 cores, replaced by ST721 |
|
205.44 € |
- |
US Biomax |
| BC01014 |
Stomach carcinoma tissue array (multi_tissue combined panel), 71 cases _72 cores, replaced by ST807 |
|
296.60 € |
- |
US Biomax |
| BC01022 |
Stomach adenocarcinoma (combination of adjacent and normal) tissue array, 21 cases _63 cores |
|
205.44 € |
- |
US Biomax |
| BC01023 |
Stomach adenocarcinoma (combination of adjacent and normal) tissue array, 21 cases _63 cores |
|
205.44 € |
- |
US Biomax |
| BC01024 |
Stomach adenocarcinoma (combination of adjacent and normal) tissue array, 21 cases _63 cores |
|
205.44 € |
- |
US Biomax |
| BC01071 |
Carcinoma of stomach, liver and rectum tissue array, 45 cases _48 cores |
|
205.44 € |
- |
US Biomax |
| BC01071a |
Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases_48 cores, replacing BC01071; ihc Anti-Actin confirmed |
|
237.54 € |
- |
US Biomax |
| BC01081 |
Adenocarcinoma of stomach, colon and rectum high density tissue array, 556 cases_616 cores |
|
585.50 € |
- |
US Biomax |
| BC01114 |
Stomach adenocarcinoma with matched adjacent tissue and normal tissue array, including TNM, clinical stage and pathology grade, 55 cases_100 cores |
|
296.60 € |
- |
US Biomax |
| BC02011 |
Multiple esophageal cancer tissue array, 69 cases_72 cores |
|
205.44 € |
- |
US Biomax |
| BC02012 |
Esophageal carcinoma (multi_tissue combined panel) tissue array, 72 cases_72 cores |
|
205.44 € |
- |
US Biomax |
| BC02013 |
Esophageal carcinoma (multi_tissue combined panel) tissue array, 72 cases_72 cores |
|
205.44 € |
- |
US Biomax |
| BC02021 |
Esophagus squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases_54 cores |
|
205.44 € |
- |
US Biomax |
| BC02022 |
Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases_54 cores |
|
205.44 € |
- |
US Biomax |
| BC02023 |
Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases_54cores, replaced by ES722 |
|
205.44 € |
- |
US Biomax |
| BC02111 |
Esophagus adenocarcinoma and normal tissue array, 23 cases_80 cores |
|
242.68 € |
- |
US Biomax |
| BC03002 |
Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases_80 cores |
|
341.54 € |
- |
US Biomax |
| BC03011 |
Liver carcinoma (multi_tissue combined panel) tissue array, 63 cases_63 cores, replaced by LV8010 |
|
205.44 € |
- |
US Biomax |
| BC03013 |
Liver carcinoma (multi_tissue combined panel) tissue array, 63 cases_63 cores, replaced by LV723 |
|
205.44 € |
- |
US Biomax |
| BC03021 |
Liver carcinoma (combination of adjacent and normal) tissue array, 42 cases_63 cores, replaced by LV803 |
|
296.60 € |
- |
US Biomax |
| BC03116 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases_70 cores |
|
296.60 € |
- |
US Biomax |
| BC03118 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases_200 cores |
|
585.50 € |
- |
US Biomax |
| BC03119 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases_120 cores |
|
356.95 € |
- |
US Biomax |
| BC04002 |
Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases_100 cores |
|
341.54 € |
- |
US Biomax |
| BC04011 |
Lung cancer tissue array, including pathology grade, 23 cases_63 cores, replaced by LC721; ihc Anti-Cytokeratin (CK) confirmed |
|
237.54 € |
- |
US Biomax |
| BC04012 |
Lung carcinoma (multi_tissue combined panel) tissue array, 68 cases_72 cores |
|
205.44 € |
- |
US Biomax |
| BC04013 |
Non_small cell lung carcinoma tissue array, 63 cases_63 core, replaced by LC806 |
|
205.44 € |
- |
US Biomax |
| BC04014 |
Non_small cell lung carcinoma (NSCLC) tissue array, 63 cases_63 cores, replaced by LC807 |
|
205.44 € |
- |
US Biomax |
| BC04015 |
Lung carcinoma (multi_tissue combined panel) tissue array, 23 cases_63 cores |
|
205.44 € |
- |
US Biomax |
| BC04016 |
Lung carcinoma tissue array, 72 cases_72 cores, replaced by LC726 |
|
205.44 € |
- |
US Biomax |
| BC04021 |
Lung carcinoma (multi_tissue combined panel) tissue array, 72 cases _72 cores |
|
205.44 € |
- |
US Biomax |
| BC04022 |
Non_small cell lung carcinoma (NSCLC)(combination of adjacent and normal) tissue array, 18 cases_54 cores |
|
205.44 € |
- |
US Biomax |
| BC041114 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases_200 cores |
|
585.50 € |
- |
US Biomax |
| BC041115 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases_120 cores |
|
356.95 € |
- |
US Biomax |
| BC041115a |
Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases_120 cores, replacing BC041115; ihc Anti-Actin confirmed |
|
380.06 € |
- |
US Biomax |
| BC04118 |
Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases_100 cores |
|
296.60 € |
- |
US Biomax |
| BC04119 |
Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases_40 cores, replaced by BC04119b |
|
296.60 € |
- |
US Biomax |
| BC04119b |
Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases_40 cores, replacing BC04119 |
|
358.01 € |
- |
US Biomax |
| BC05002 |
Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases_80 cores |
|
341.54 € |
- |
US Biomax |
| BC05011 |
Multiple types of colon carcinoma tissue array, 72 cases_72 cores, replaced by CO804 |
|
296.60 € |
- |
US Biomax |
| BC050112 |
Colon metastatic carcinoma tissue array, 23 cases_63 cores, replaced by CO726 |
|
296.60 € |
- |
US Biomax |
| BC05012 |
Colon carcinoma (multi_tissue combined panel) tissue array, 70 cases_72 cores. |
|
296.60 € |
- |
US Biomax |
| BC05021 |
Colon adenocarcinoma (combination of adjacent and adjacent normal) tissue array, 18 cases_54 cores, no overlapping with BC05022, replaced by CO722 |
|
296.60 € |
- |
US Biomax |
| BC05022 |
Colon adenocarcinoma (combination of adjacent and normal) tissue array, 18 cases_54 cores, no overlapping with BC05021 |
|
296.60 € |
- |
US Biomax |
| BC05023 |
Colon adenocarcinoma (combination of adjacent and normal) tissue array, with grade and stage (TNM) info, 18 cases_54 cores |
|
296.60 € |
- |
US Biomax |
| BC051110 |
Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases_120 cores |
|
356.95 € |
- |
US Biomax |
| BC051111 |
Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases_200 cores |
|
585.50 € |
- |
US Biomax |
| BC05115 |
Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases_69 cores, replaced by CO702 |
|
296.60 € |
- |
US Biomax |
| BC05118 |
Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases_100 cores |
|
341.54 € |
- |
US Biomax |
| BC05118a |
Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases_100 cores, replacing BC05118; ihc Anti-Actin confirmed |
|
380.06 € |
- |
US Biomax |
| BC06002 |
Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases_72 cores |
|
342.78 € |
- |
US Biomax |
| BC06011 |
Rectum carcinoma (multi_tissue combined panel) tissue array, 71 cases_72 cores |
|
205.44 € |
- |
US Biomax |
| BC06022 |
Rectum carcinoma (combination of adjacent and normal) tissue array, 18 cases_54 cores, replaced by RE722 |
|
205.44 € |
- |
US Biomax |
| BC07001 |
Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases_80 cores |
|
342.78 € |
- |
US Biomax |
| BC07011 |
Kidney carcinoma (multi_tissue combined panel) tissue array, 23 cases_63 cores, replaced by BC07013 |
|
205.44 € |
- |
US Biomax |
| BC07012 |
Kidney carcinoma (multi_tissue combined panel) tissue array, 72 cases_72 cores, replaced by BC07015 |
|
205.44 € |
- |
US Biomax |
| BC07013 |
Kidney carcinoma (multi_tissue combined panel) tissue array, 23 cases_63 cores, replacing BC07011 |
|
205.44 € |
- |
US Biomax |
| BC07014 |
Kidney carcinoma (multi_tissue combined panel) tissue array, 72 cases_72 cores |
|
205.44 € |
- |
US Biomax |
| BC07014a |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases_72 cores, replacing BC07014; ihc Anti-Actin confirmed |
|
237.54 € |
- |
US Biomax |
| BC07015 |
Multiple type kidney cancer tissue array with normal tissues, 71 cases_72 cores, replacing BC07012 |
|
296.60 € |
- |
US Biomax |
| BC07114 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 100 cases_200 cores |
|
586.53 € |
- |
US Biomax |
| BC07115 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 120 cases_120 cores |
|
342.78 € |
- |
US Biomax |
| BC08013 |
Breast carcinoma (multi_tissue combined panel) tissue array, 63 cases_63 cores, replaced by BC08014 |
|
205.44 € |
- |
US Biomax |
| BC08014 |
Breast cancer (multiple types of breast cancer) tissue array, 63 cases_63 cores, replaced by BR8018 |
|
205.44 € |
- |
US Biomax |
| BC08015 |
Breast carcinoma (multi_tissue combined panel) tissue array, 22 cases_63 cores, replaced by BR728 |
|
205.44 € |
- |
US Biomax |
| BC08016 |
Breast carcinoma (multi_tissue combined panel) tissue array, 63 cases_63 cores, replaced by BR803 |
|
205.44 € |
- |
US Biomax |
| BC08022 |
Breast carcinoma (combination of adjacent and normal) tissue array, 53 cases_63 cores, replacing BN08021 |
|
205.44 € |
- |
US Biomax |
| BC08023 |
Breast carcinoma (combination of adjacent and normal) tissue array, 57 cases_63 cores |
|
296.60 € |
- |
US Biomax |
| BC08032 |
Infiltrating duct carcinoma (combination of adjacent and normal) tissue array, 57 cases_63 cores |
|
296.60 € |
- |
US Biomax |
| BC081115 |
Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases_110 cores, replaced by BC081120 |
|
356.95 € |
- |
US Biomax |
| BC081116 |
Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases_110 cores |
|
356.95 € |
- |
US Biomax |
| BC081120 |
Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases_110 cores, replacing BC081115 |
|
341.54 € |
- |
US Biomax |
| BC08118 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases_100 cores |
|
342.78 € |
- |
US Biomax |
| BC09012 |
Endometrial carcinoma (multi_tissue combined panel) tissue array, 63 cases_63 cores |
|
296.60 € |
- |
US Biomax |
| BC10021 |
Cervix carcinoma (combination of margin and normal tissues) tissue array, 64 cases_72 cores |
|
296.60 € |
- |
US Biomax |
| BC10025 |
Cervical cancer and normal tissue array, 54 cases_54 cores |
|
296.60 € |
- |
US Biomax |
| BC11011 |
Ovarian carcinoma (multi_tissue combined panel) tissue array (replaced by OV802), 70 cases_72 cores |
|
205.44 € |
- |
US Biomax |
| BC110118 |
Ovarian cancer tissue array, including TNM and pathology grade, 72 cases_72 cores, replacing BC11012 |
|
296.60 € |
- |
US Biomax |
| BC11012 |
Ovarian carcinoma (multi_tissue combined panel) tissue array, 70 cases_72 cores |
|
205.44 € |
- |
US Biomax |
| BC11012a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases_72 cores, replacing BC11012; ihc Anti-Actin confirmed |
|
237.54 € |
- |
US Biomax |
| BC111109 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases_70 cores |
|
296.60 € |
- |
US Biomax |
| BC111110 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases_70 cores |
|
296.60 € |
- |
US Biomax |
| BC11115 |
Ovary serous papillary adenocarcinoma, lymph node metastasis with adjacent normal ovary tissue array, including TNM and pathology grade, 100 cases_100 cores |
|
342.78 € |
- |
US Biomax |
| BC12011a |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases_63 cores, replacing BC12011; ihc Anti-Actin confirmed |
|
208.01 € |
- |
US Biomax |
| BC12012 |
Bladder carcinoma (multi_tissue combined panel) tissue array, 63 cases_63 cores, replaced by BL802 |
|
296.60 € |
- |
US Biomax |
| BC14012 |
Pancreatic cancer (multi_tissue combined panel), 24 cases_63 cores, replaced by PA721 |
|
297.08 € |
- |
US Biomax |
| BC15012 |
Thyroid carcinoma (multi_tissue combined panel) tissue array, 23 cases_63 cores |
|
296.60 € |
- |
US Biomax |
| BC17012 |
Medulloblastoma of brain tissue array, 100 cases_100 cores |
|
297.08 € |
- |
US Biomax |
| BC17013 |
Brain astrocytoma and meningioma tissue array, 120 cases_120 cores |
|
342.78 € |
- |
US Biomax |
| BC19012 |
Prostate carcinoma (multi_tissue combined panel) tissue array, 33 cases_63 cores, replaced by PR808 |
|
296.60 € |
- |
US Biomax |
| BC19013 |
Prostate carcinoma (multi_tissue combined panel) tissue array, 33 cases_63 cores |
|
296.60 € |
- |
US Biomax |
| BC19014 |
Prostate carcinoma tissue array, 31 cases_63 cores |
|
296.60 € |
- |
US Biomax |
| BC19015 |
Prostate carcinoma tissue array, 9 cases_27 cores |
|
205.44 € |
- |
US Biomax |
| BC19017 |
Prostate carcinoma tissue array, 33 cases_63 cores, replaced by PR809 |
|
205.44 € |
- |
US Biomax |
| BC19019 |
Prostate cancer and hyperplasia tissue array, 33 cases_63 cores, replacing BC19011 |
|
296.60 € |
- |
US Biomax |
| BC19021 |
Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases_72 cores |
|
341.54 € |
- |
US Biomax |
| BC19111 |
Normal prostate tissue array, with prostate tumor and hyperplasia, 11 cases_30 cores |
|
205.44 € |
- |
US Biomax |
| BC21011 |
Skin malignant tumor tissue array, 78 cases_78 cores (squamous carcinoma, adenocarcinoma, basal cell carcinoma, sarcoma, melanoma), replaced by BC21014 |
|
296.60 € |
- |
US Biomax |
| BC21014 |
Skin malignant tumor tissue array, 78 cases_78 cores, replacing BC21011 |
|
296.60 € |
- |
US Biomax |
| BC23011 |
Testis tumor combination, 24 cases_72 cores |
|
296.60 € |
- |
US Biomax |
| BC23012 |
Testis tumor tissue array, 23 cases_63 cores |
|
296.60 € |
- |
US Biomax |
| BC24011 |
Soft tissue tumor (multi_tissue combined panel) tissue array, 63 cases_63 cores |
|
296.60 € |
- |
US Biomax |
| BC24021 |
Leiomyosarcoma and Rhabdomyosarcoma tissue array with normal muscles controls, 39 cases_75 cores |
|
296.60 € |
- |
US Biomax |
| BC27011 |
Multiple organs, diseased tissue array of oral cavity, 47 cases_48 cores |
|
242.68 € |
- |
US Biomax |
| BC30011 |
Heart tissue array, 13 cases_34 cores, replaced by BC30013 |
|
296.60 € |
- |
US Biomax |
| BC30013 |
Heart disease and normal tissue array, replacing BC30011, 18 cases_36 cores |
|
296.60 € |
- |
US Biomax |
| BC34011 |
Head and neck squamous cell carcinoma tissue array, 24 cases_63 cores |
|
205.44 € |
- |
US Biomax |
| BC34111 |
Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases_72 cores, replaced by HN811 |
|
205.44 € |
- |
US Biomax |
| BC35111 |
Retinoblastoma and normal adjacent tissue array, 17 cases_34 cores |
|
242.68 € |
- |
US Biomax |
| BCN721 |
Multiple cancer (12 common types) tissue array with unmatched normal adjacent tissue, 71 cases_72 cores |
|
296.60 € |
- |
US Biomax |
| BCN801 |
Multiple organ cancer with adjacent tissue combined panel tissue array, 48 cases_80 cores |
|
296.60 € |
- |
US Biomax |
| BCN961 |
Multiple organ cancer tissue array with adjacent cancer tissue control tissue array, 57 cases_96 cores, replaced by BCN963 |
|
296.60 € |
Peptides |
US Biomax |
| BCN962 |
Combined multiple normal and cancer tissue array, containing germline, embryonic tumors and normal adjacent tissue, 60 cases_96 cores |
|
296.60 € |
Peptides |
US Biomax |
| BCN963 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases_96 cores, replacing BCN961 |
|
341.54 € |
Peptides |
US Biomax |
| BCN963a |
Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases_96 cores, replacing BCN963; ihc Anti-Actin confirmed |
|
331.27 € |
Peptides |
US Biomax |
| BE01014 |
Multiple organ, normal fetus tissue array, 26 cases_78 cores |
|
242.68 € |
- |
US Biomax |
| BE01015 |
Multiple organ, normal fetus tissue array, 50 cases_50 cores |
|
242.68 € |
- |
US Biomax |
| BL1001 |
Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases_100 cores |
|
341.54 € |
- |
US Biomax |
| BL1002 |
Bladder cancer and normal tissue array, including TNM and pathology grade, 50 cases_100 cores |
|
341.54 € |
- |
US Biomax |
| BL1501 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases_150 cores; ihc Anti-Actin confirmed |
|
331.27 € |
- |
US Biomax |
| BL1921 |
Mid_advanced stage bladder cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases_192 cores |
|
585.50 € |
Peptides |
US Biomax |
| BL208 |
Tissue microarray of bladder cancer and normal tissue, high density (69 cases_208 cores) with grade and stage data |
|
585.50 € |
- |
US Biomax |
| BL2081 |
Bladder cancer high density tissue array, 203 cases_208 cores |
|
585.50 € |
- |
US Biomax |
| BL2082 |
Bladder disease spectrum (bladder cancer progression) tissue array, 202 cases_208 cores |
|
585.50 € |
- |
US Biomax |
| BL241 |
Bladder cancer tissue array with self_matching normal adjacent tissues, 10 cases_24 cores |
|
112.99 € |
- |
US Biomax |
| BL242 |
Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases_48 cores |
|
242.68 € |
- |
US Biomax |
| BL243 |
Bladder cancer tissue array with normal tissues from autopsy, 12 cases_24 cores with stage and grade data |
|
128.40 € |
- |
US Biomax |
| BL244 |
Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases_24 cores; ihc Anti-Actin confirmed |
|
134.82 € |
- |
US Biomax |
| BL481 |
Bladder cancer tissue array with unmatched normal adjacent tissues, 48 cases_48 cores, with stage and grade data |
|
242.68 € |
- |
US Biomax |
| BL482 |
Bladder cancer tissue array, including TNM and pathology grade, 48 cases_48 cores |
|
242.68 € |
- |
US Biomax |
| BL801 |
Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases_80 cores, replaced by BL806 |
|
341.54 € |
- |
US Biomax |
| BL802 |
Bladder cancer tissue array with normal tissue, 80 cases_80 cores, replacing BC12012 |
|
341.54 € |
- |
US Biomax |
| BL803 |
Bladder cancer and normal tissue array with TNM and grade data, 40 cases_80 cores |
|
341.54 € |
- |
US Biomax |
| BL804 |
Bladder disease spectrum (urocystic cancer progression) tissue array, 80 cases_80 cores |
|
341.54 € |
- |
US Biomax |
| BL805 |
Mid_advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases_80 cores |
|
341.54 € |
- |
US Biomax |
| BL806 |
Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases_80 cores, replacing BL801 |
|
341.54 € |
- |
US Biomax |
| BLC1501 |
Bladder cancer mid_density tissue array, 75 cases_150 cores |
|
335.12 € |
- |
US Biomax |
| BLC241 |
Bladder cancer tissue array, 12 cases_24 cores |
|
242.68 € |
- |
US Biomax |
| BLC661 |
Bladder cancer tissue array, 33 cases_66 cores |
|
288.90 € |
- |
US Biomax |
| BM01011 |
Liver, kidney, lung, muscle, brain, heart, stomach, spleen tissue array, 160 cases_160 cores, replaced by MO1601 |
|
356.95 € |
- |
US Biomax |
| BM241 |
Bone marrow tissue array, 12 cases_24 cores |
|
112.99 € |
- |
US Biomax |
| BM481 |
Normal bone marrow tissue array, 24 cases_48 cores |
|
205.44 € |
- |
US Biomax |
| BM482 |
Multiple myeloma tissue microarray with normal tissue as control, 24 cases_48 cores, replaced by BM483 |
|
509.75 € |
- |
US Biomax |
| BM483 |
Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases_48 cores, replacing BM482 |
|
341.54 € |
- |
US Biomax |
| BN00011 |
Multiple organ normal tissue array, 48 cases_48 cores |
|
205.44 € |
- |
US Biomax |
| BN00015 |
Multiple organ normal tissue array, 47 cases_48 cores |
|
205.44 € |
- |
US Biomax |
| BN00112 |
Multiple organ normal tissue array, 40cases_40 cores, replaced by BN00119 |
|
205.44 € |
- |
US Biomax |
| BN00119 |
Multiple organ normal tissue array, 40 cases_40 cores, replacing BN00112 |
|
341.54 € |
- |
US Biomax |
| BN01011 |
Normal stomach tissue (multi_sites) array, 21 cases _63 cores, replaced by BN01011b |
|
205.44 € |
- |
US Biomax |
| BN01011b |
Normal stomach tissue array, 24 cases_72 cores, replacing BN01011 |
|
297.08 € |
- |
US Biomax |
| BN01013 |
Normal stomach tissue (multi_sites) array, 70 cases _72 cores |
|
205.44 € |
- |
US Biomax |
| BN03011 |
Normal liver tissue array (multi_sites), 20 cases_63 cores, replaced by LVN801 |
|
205.44 € |
- |
US Biomax |
| BN04011 |
Normal lung tissue (multi_sites) tissue array, 22 cases_63 cores, replaced by LC725 |
|
205.44 € |
- |
US Biomax |
| BN05011 |
Normal colon tissue (multi_site) array, 23 cases_63 cores, replaced by BN05014 |
|
205.44 € |
- |
US Biomax |
| BN05014 |
Colon normal tissue array, including TNM and pathology grade of 3 cases adenocarcinoma, 24 cases_72 cores, replacing BN05011 |
|
205.44 € |
- |
US Biomax |
| BN06011 |
Normal rectum tissue (multi_sites) tissue array, 23 cases_63 cores |
|
205.44 € |
- |
US Biomax |
| BN06012 |
Normal rectum tissue (multi_sites) tissue array, 70 cases_72 cores |
|
205.44 € |
- |
US Biomax |
| BN07011 |
Normal kidney tissue array (multi_sites), 20 cases_54 cores |
|
205.44 € |
- |
US Biomax |
| BN07012 |
Normal kidney tissue (multi_sites) tissue array, 70 cases_72 cores, replaced by KD803 |
|
205.44 € |
- |
US Biomax |
| BN08013 |
Normal breast tissue (multi_sites) array, 71 cases_72 cores, replaced by BRN801 |
|
205.44 € |
- |
US Biomax |
| BN08111 |
Breast hyperplasia and normal tissue array, 10 cases_30 cores |
|
296.60 € |
- |
US Biomax |
| BN1002 |
Multiple organ (20) normal tissue array, 100 cases_100 cores, replacing BN1001 |
|
341.54 € |
- |
US Biomax |
| BN1002a |
Multiple organ normal tissue array, 100 cases_100 cores, replacing BN1002; ihc Anti-Actin confirmed |
|
380.06 € |
- |
US Biomax |
| BN113 |
Multiple organ normal tissue array, replaced by BN126, 45 cases_45 cores |
|
242.68 € |
- |
US Biomax |
| BN114 |
Multiple normal human organ tissue array, 48 cases_48 cores |
|
242.68 € |
- |
US Biomax |
| BN115 |
Multiple organ normal tissue array, 46 cases_46 cores |
|
242.68 € |
- |
US Biomax |
| BN116 |
Multiple organ normal tissue array, 48 cases_48 cores, replaced by BN129 |
|
242.68 € |
- |
US Biomax |
| BN117 |
Multiple organ normal tissue array, 45 cases_45 cores |
|
242.68 € |
- |
US Biomax |